224 related articles for article (PubMed ID: 24956294)
1. Update on prognostic markers for endometrial cancer.
Binder PS; Mutch DG
Womens Health (Lond); 2014 May; 10(3):277-88. PubMed ID: 24956294
[TBL] [Abstract][Full Text] [Related]
2. Management of endometrial cancer.
Fowler W; Mutch D
Womens Health (Lond); 2008 Sep; 4(5):479-89. PubMed ID: 19072487
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers as prognostic factors in endometrial cancer.
Dobrzycka B; Terlikowski SJ
Folia Histochem Cytobiol; 2010 Sep; 48(3):319-22. PubMed ID: 21071332
[TBL] [Abstract][Full Text] [Related]
4. [Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].
Wen HW; Tian F; Ma L; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):196-9. PubMed ID: 19570445
[TBL] [Abstract][Full Text] [Related]
5. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
7. [The validity of chemotherapy in the treatment of endometrial cancer].
Fehr MK; Streich MS
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):34-8. PubMed ID: 16452818
[TBL] [Abstract][Full Text] [Related]
8. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
9. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
Curtin JP; Shapiro F
Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
[TBL] [Abstract][Full Text] [Related]
11. [Update on postoperative chemotherapy for endometrial cancer].
Tsujioka H; Hachisuga T; Kawarabayashi T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():351-5. PubMed ID: 15535266
[No Abstract] [Full Text] [Related]
12. Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings.
Maneschi F; Ceccacci I; Perugini A; Pane C; Simeone A; Manicone A
Arch Gynecol Obstet; 2012 Feb; 285(2):521-7. PubMed ID: 21779772
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemo-radiotherapy in the "sandwich" method for high risk endometrial cancer--a review of literature.
Bie Y; Zhang Z; Wang X
BMC Womens Health; 2015 Jun; 15():50. PubMed ID: 26104468
[TBL] [Abstract][Full Text] [Related]
14. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.
Shah PH; Kudrimoti M; Feddock J; Randall M
Gynecol Oncol; 2011 Sep; 122(3):675-83. PubMed ID: 21664661
[TBL] [Abstract][Full Text] [Related]
16. Management of advanced-stage and recurrent endometrial cancer.
Ray M; Fleming G
Semin Oncol; 2009 Apr; 36(2):145-54. PubMed ID: 19332249
[TBL] [Abstract][Full Text] [Related]
17. USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.
Vogel RI; Pulver T; Heilmann W; Mooneyham A; Mullany S; Zhao X; Shahi M; Richter J; Klein M; Chen L; Ding R; Konecny G; Kommoss S; Winterhoff B; Ghebre R; Bazzaro M
Oncotarget; 2016 May; 7(21):30962-76. PubMed ID: 27121063
[TBL] [Abstract][Full Text] [Related]
18. What's new in systemic therapy for endometrial cancer.
Kieser K; Oza AM
Curr Opin Oncol; 2005 Sep; 17(5):500-4. PubMed ID: 16093803
[TBL] [Abstract][Full Text] [Related]
19. CA 125 normalization with chemotherapy is independently predictive of survival in advanced endometrial cancer.
Hoskins PJ; Le N; Correa R
Gynecol Oncol; 2011 Jan; 120(1):52-5. PubMed ID: 20947152
[TBL] [Abstract][Full Text] [Related]
20. Biologic markers in endometrial cancer treatment.
Engelsen IB; Akslen LA; Salvesen HB
APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
